| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/27/2004 | DE10253154A1 Biosensor, used to identify analyte in liquid sample, has test field with detector, where detector registers field changes as electrical signals for evaluation |
| 05/27/2004 | DE10252926A1 Sample holder, for schnapps distillation installation, has sample measuring tap |
| 05/27/2004 | DE10252239A1 Printing biomolecules on to surfaces, useful particularly in biotechnology for immobilizing nucleic acids and proteins, with addition of disaccharide to printing solution, as stabilizer and to increase viscosity |
| 05/27/2004 | DE10252223A1 Vorrichtung zur Separierung und Ausgabe von Plasma Apparatus for separating and discharging plasma |
| 05/27/2004 | DE10251767A1 Vorrichtung und Verfahren zur Messung elektrischer Vorgänge an biologischen Membranen Apparatus and method for measuring electrical activity of biological membranes |
| 05/27/2004 | DE10152041B4 Vorrichtung und Verfahren zum Messen/Prüfen physikalischer Eigenschaften an Materialproben Apparatus and method for measuring / testing physical properties of material samples |
| 05/27/2004 | CA2757475A1 Compositions and methods for the treatment of natural killer cell related diseases |
| 05/27/2004 | CA2545930A1 Tumour marker proteins and uses thereof |
| 05/27/2004 | CA2505974A1 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same |
| 05/27/2004 | CA2505924A1 Method for identifying antigen specific b cells |
| 05/27/2004 | CA2505923A1 Antibody-or neutrophil-mediated ozone generation |
| 05/27/2004 | CA2505921A1 Diagnosis of sepsis or sirs using biomarker profiles |
| 05/27/2004 | CA2505902A1 Diagnosis of sepsis or sirs using biomarker profiles |
| 05/27/2004 | CA2505843A1 Diagnosis of sepsis or sirs using biomarker profiles |
| 05/27/2004 | CA2505785A1 Diagnosis of sepsis or sirs using biomarker profiles |
| 05/27/2004 | CA2505546A1 Molecules preferentially associated with effector t cells and methods of their use |
| 05/27/2004 | CA2505472A1 Methods for identifying dna copy number changes |
| 05/27/2004 | CA2505355A1 Methods for predicting whether subjects with mild cognitive impairment (mci) will develop alzheimer's disease |
| 05/27/2004 | CA2505250A1 Acetylated hmgb1 protein |
| 05/27/2004 | CA2505125A1 Assay for autoantibodies to folate receptors |
| 05/27/2004 | CA2504953A1 A new target for angiogenesis and anti-angiogenesis therapy |
| 05/27/2004 | CA2504818A1 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 05/27/2004 | CA2504670A1 Combinatorial libraries of monomer domains |
| 05/27/2004 | CA2504607A1 Methods and compositions for treating neurological disorders |
| 05/27/2004 | CA2504605A1 Treatment of chronic lymphocytic leukemia and prostate cancer with microrna mir15 |
| 05/27/2004 | CA2504508A1 Methods and compositions for prostate epithelial cell differentiation |
| 05/27/2004 | CA2504042A1 Methods and materials for examining pathways associated with glioblastoma progression |
| 05/27/2004 | CA2503797A1 Systems and methods of sorting samples |
| 05/27/2004 | CA2503787A1 Methods of isolation of active compounds and activated targets |
| 05/27/2004 | CA2503785A1 Anaerobic fermentation method and apparatus |
| 05/27/2004 | CA2503672A1 Growth hormone variations in humans and its uses |
| 05/27/2004 | CA2503631A1 Microparticle-based methods and systems and applications thereof |
| 05/27/2004 | CA2503626A1 A methodology of estimating the conformation of a protein by proteolysis |
| 05/27/2004 | CA2503621A1 Methods and compositions for diagnosing dysplasia |
| 05/27/2004 | CA2502926A1 Uncoupled collagen synthesis and degradation assays |
| 05/27/2004 | CA2502822A1 High throughput automatic nucleic acid isolation and quantitation methods |
| 05/27/2004 | CA2492486A1 Photometric determination of coagulation time in undiluted whole blood |
| 05/26/2004 | EP1422527A1 Glycine N-methyltransferase monoclonal antibodies and methods of use therefore in the detection of cancer |
| 05/26/2004 | EP1422526A1 Method for improved diagnosis of dysplasias |
| 05/26/2004 | EP1422525A1 Assays for Trichomonas vaginalis |
| 05/26/2004 | EP1422524A1 Screening method |
| 05/26/2004 | EP1422523A1 Determination of sample volume adequacy in biosensors |
| 05/26/2004 | EP1422514A1 Method of evaluating uniformity of spots in arrays |
| 05/26/2004 | EP1422510A1 Improved apparatus and method for the detection and measurement of particulates in molten metal |
| 05/26/2004 | EP1422509A1 Lysing Reagent and Method of Lysing Red Blood Cells for Hematology |
| 05/26/2004 | EP1422493A1 Device and method for identifying metal body |
| 05/26/2004 | EP1422298A2 Detection of hiv-1 by nucleic acid amplification |
| 05/26/2004 | EP1422297A1 Method of testing for bronchial asthma |
| 05/26/2004 | EP1422241A1 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 05/26/2004 | EP1421993A1 Apparatus for separating and delivering plasma |
| 05/26/2004 | EP1421952A1 Myocardial cell apoptosis inhibitors |
| 05/26/2004 | EP1421951A2 Conserved motif of hepatitis C virus E2/NS1 region |
| 05/26/2004 | EP1421939A1 Sustained release preparation of a macrolide compound like tacrolimus |
| 05/26/2004 | EP1421906A1 Urine collecting container and accessory devices |
| 05/26/2004 | EP1421904A1 Arrangement for passive gas sampling |
| 05/26/2004 | EP1421901A2 Arrangement for passive gas sampling |
| 05/26/2004 | EP1421895A1 Method and apparatus for localizing light emitting areas |
| 05/26/2004 | EP1421841A2 Combine harvester |
| 05/26/2004 | EP1421539A2 Stabilized proteins with engineered disulfide bonds |
| 05/26/2004 | EP1421408A1 Measurement of air characteristics in the lower atmosphere |
| 05/26/2004 | EP1421391A2 Sodium channel regulators and modulators |
| 05/26/2004 | EP1421389A2 Neurofibrillary labels |
| 05/26/2004 | EP1421388A2 Diagnosis of carcinomas |
| 05/26/2004 | EP1421387A2 Cellular immunity test with peptides fixed on a solid support |
| 05/26/2004 | EP1421386A2 High capacity assay platforms |
| 05/26/2004 | EP1421385A1 Genetic construct intracellular monitoring system |
| 05/26/2004 | EP1421384A2 Hprp4s as modifiers of the p53 pathway and methods of use |
| 05/26/2004 | EP1421383A2 Method to identify modulators for human 3-alpha-hydroxysteroid dehydrogenase |
| 05/26/2004 | EP1421382A1 Methdo and arrangement for analyzing substances |
| 05/26/2004 | EP1421379A2 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 05/26/2004 | EP1421377A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 05/26/2004 | EP1421376A2 Bioanalytical recognition surface with optimised recognition element density |
| 05/26/2004 | EP1421375A2 Method and apparatus for determination of water and for normal phase liquid chromatography |
| 05/26/2004 | EP1421372A2 Method and apparatus for calibrating electrochemical sensors |
| 05/26/2004 | EP1421371A1 Biosensor |
| 05/26/2004 | EP1421369A2 Sensor |
| 05/26/2004 | EP1421350A1 Combined fluid condition monitor and fluid level sensor |
| 05/26/2004 | EP1421222A2 Cell culture system for synthesis of infectious hepatitis c virus |
| 05/26/2004 | EP1421221A2 Methods for diagnosing and treating neoplasias using nf-at transcription factors |
| 05/26/2004 | EP1421220A2 Method and nucleic acids for the analysis of colon cancer |
| 05/26/2004 | EP1421218A2 Model of autoimmune disease and methods for identifying agents against autoimmune disease |
| 05/26/2004 | EP1421216A1 Method for manufacturing hydrogel biochip by using star-like polyethylene glycol derivative having epoxy group |
| 05/26/2004 | EP1421214A2 Amplified oncogenes and their involvement in cancer |
| 05/26/2004 | EP1421213A2 Labeled nucleoside polyphosphates |
| 05/26/2004 | EP1421211A2 Methods for detecting dna originating from different individuals |
| 05/26/2004 | EP1421210A2 Method of detecting protease activity in a cell |
| 05/26/2004 | EP1421209A2 Satterned composite membrane and stenciling method for the manufacture thereof |
| 05/26/2004 | EP1421207A2 Method for the detection of cytochrome b mutations in fungi |
| 05/26/2004 | EP1421206A2 Improved method for measuring membrane potential |
| 05/26/2004 | EP1421204A2 Iap binding peptides and assays for identifying compounds that bind iap |
| 05/26/2004 | EP1421201A2 Methods for immobilizing molecules to a solid phase and uses thereof |
| 05/26/2004 | EP1421198A2 Cell-based high-throughput screening methods |
| 05/26/2004 | EP1421192A1 Regulation of human ptpase-like protein |
| 05/26/2004 | EP1421189A2 Method and device for integrated protein expression, purification and detection |
| 05/26/2004 | EP1421176A2 Nucleic acids and encoded polypeptides associated with bipolar disorder |
| 05/26/2004 | EP1421175A2 Polymer stabilized proteinases |
| 05/26/2004 | EP1421174A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 05/26/2004 | EP1421172A2 Artificial synapse chip interface for electronic prosthetic retina |
| 05/26/2004 | EP1421117A2 Compositions and methods for generating chimeric heteromultimers |
| 05/26/2004 | EP1421115A2 Soluble t cell receptor |